Globus Medical

Healthcare · Medical Devices

75.60$ +1.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Globus Medical (GMED) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 790 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GMED
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	136	152	156	152	152	176	174	173	169	196	183	195	196	212	191	149	216	233	227	251	230	250	231	264	254	274	277	292	384	617	607	630	626	657	598	745	769	826	760	790	3,145
Cost of Revenue	31	39	36	37	37	41	38	38	38	46	42	44	45	49	49	51	57	61	55	64	59	62	59	68	65	71	71	76	135	265	241	260	271	263	195	249	282	231	234	241	989
Gross Profit	104	113	120	115	115	135	136	136	131	150	141	151	151	163	142	98	159	173	172	187	171	188	171	195	189	204	206	215	248	351	365	370	355	394	403	497	487	595	526	548	2,156
Research & Development	10	14	11	11	11	11	13	14	16	14	14	16	15	15	15	39	14	15	15	16	16	51	17	17	19	20	21	21	29	52	57	38	35	33	33	40	38	74	37	36	185
Selling, General & Administrative	54	61	67	64	63	73	76	77	75	84	86	88	88	92	94	80	89	92	98	107	96	107	101	107	107	118	122	120	156	245	249	238	241	253	243	304	314	318	298	287	1,217
Total Operating Expenses	67	77	80	78	79	87	91	94	93	107	104	108	109	113	113	124	109	114	118	141	118	170	125	127	129	150	149	149	248	341	357	320	307	334	306	420	352	423	364	366	1,505
Operating Income	38	36	40	37	36	48	46	42	38	43	37	43	42	50	28	-26	50	59	55	46	53	18	46	68	60	54	56	66	0.4	10	8.0	50	48	60	97	76	135	172	164	182	653
Interest Expense	0.8	1.2	1.4	1.6	1.7	1.9	2.3	3.0	3.9	4.2	4.2	4.4	4.4	4.5	4.3	3.6	3.1	3.0	2.7	2.5	2.1	1.9	2.5	2.5	3.9	5.3	6.5	8.3	7.9	2.6	1.9	2.3	0.8	0.8	–	0.7	1.5	–	5.4	–	–
Pre-Tax Income	39	36	42	40	37	51	48	50	43	48	42	47	47	54	32	-22	53	62	57	49	54	20	49	71	61	62	63	75	2.5	25	-8.6	48	57	25	104	188	144	174	157	190	665
Income Tax Expense	13	12	14	11	12	26	8.5	5.3	7.4	11	8.4	8.9	8.4	8.9	6.5	-1.1	8.9	9.3	12	7.4	7.2	4.7	11	16	14	12	14	17	1.5	10.0	-1.4	16	5.2	-1.8	28	-15	25	33	33	38	129
Net Income	26	24	29	29	26	24	40	45	35	37	33	38	38	46	26	-21	44	53	45	42	47	15	38	55	47	50	49	58	1.0	15	-7.1	32	52	27	75	203	119	141	124	152	535
EBITDA	46	53	53	49	46	57	55	57	49	55	50	56	58	62	44	-10	68	77	72	79	71	43	66	84	77	79	76	87	86	97	85	126	116	145	164	193	215	244	227	190	876

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings